Lionsgate Studios Corp. (LION) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
LION currently has 289M outstanding shares. with limited dilution risk as only 366K additional shares (0.1%) are authorized for issuance. The company has minimally diluted shareholders by 6.21% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 27, 2026 |
S-3 filing: This filing covers the issuance of 157,869 shares of common stock upon the exercise of outstanding stock options and stock appreciation rights under the New Lionsgate 2025 Plan. |
290M | 370K |
| Nov 07, 2025 |
10-Q filing | 289.2M shares outstanding |
290M | 0 |
| Aug 11, 2025 |
10-Q filing | 272.3M shares outstanding |
270M | 13M |
| Jul 29, 2025 |
S-1/A filing: This S-1/A filing from 2025-07-29 discusses the offering of New Lionsgate new common shares and the use of proceeds from the exercise of stock options and SARs for general corporate purposes. |
280M | 210K |
| Jul 24, 2025 |
S-1/A filing: This S-1/A filing from New Lionsgate details the offering of new common shares related to the exercise of stock options and SARs, with proceeds intended for general corporate purposes. |
280M | 210K |
| May 30, 2025 |
10-K filing | 284.6M shares outstanding |
280M | 0 |
| Mar 26, 2025 |
S-1/A filing: This S-1/A filing from 2025-03-26 relates to an offering by New Lionsgate, involving 283,853 new common shares and a total proposed amount of $100 million, with proceeds intended for general corporate purposes. |
N/A | 280K |
| Mar 24, 2025 |
S-1 filing: This S-1 filing from 2025-03-24 details a proposed offering by New Lionsgate, involving the issuance of 283,853 new common shares, with proceeds intended for general corporate purposes and the exercise of stock options under the company's plans. |
N/A | 280K |